...
首页> 外文期刊>Applied clay science >Synthesis and characterization of montmorillonite/ciprofloxacin/TiO_2 porous structure for controlled drug release of ciprofloxacin tablet with oral administration
【24h】

Synthesis and characterization of montmorillonite/ciprofloxacin/TiO_2 porous structure for controlled drug release of ciprofloxacin tablet with oral administration

机译:用口服给药的蒙脱石/环丙沙星/ TiO_2多孔结构的蒙脱石/环丙沙星/ TiO_2多孔结构

获取原文
获取原文并翻译 | 示例
           

摘要

Bio-nanocomposite materials based on montmorillonite clay and TiO2 were arranged as controlled drug delivery system for oral administration of ciprofloxacin (CPx). For this purpose, minimum amount of the commercial CPx was selected and the extension of the release period from the prepared porous structure was provided. In order to identify the MMT amount used in drug delivery process, adsorption of CPx on MMT was performed in batch system. 0.1 g MMT was found enough to adsorb 250 mg CPx with 99.2% adsorption efficiency. CPx adsorption was best described by Temkin isotherm model (R-2 = 0.96) among the other models, which indicated that the linear reduction of adsorption heat. The synthesized MMT/CPx nanocomposites, which include 0.1 g MMT, were coated with different amounts of TiO2 (10-100% wt%) to obtain MMT/CPx/TiO2 porous structure. MMT/CPx/TiO2 (10%) nanocomposite reached 100% release in 24 h in simulated gastric fluid, while MMT/CPx and commercial CPx completed the release in 15 h and 8 h in gastric fluid, respectively. The longest CPx release time in simulated blood fluid was achieved for MMT/CPx/TiO2 (30%) in 69 h. Electrostatic attractions between CPx molecule and the structure were the main reason affecting the drug delivery mechanism. Zeta potential measurements, FTIR and XRD results were also supported the experimental data. CPx release profile fitted well with Korsmeyer-Peppas kinetic model and n value was found higher than 0.89, which indicates Super Case II release mechanism.
机译:基于Montmorillonite粘土和TiO2的生物纳米复合材料被安排为用于口服施用环丙沙星(CPX)的受控药物递送系统。为此目的,选择了商业CPX的最小量,并提供了从制备的多孔结构中延伸释放期。为了鉴定药物递送过程中使用的MMT量,在批量系中进行CPX对MMT的吸附。发现0.1g MMT足以吸附250mg CPX,吸附效率为99.2%。 Temkin等温线模型(R-2 = 0.96)最佳地描述了CPX吸附,在其他模型中最佳地描述,这表明吸附热的线性减少。包括0.1g mmt的合成的MMT / CPX纳米复合材料涂有不同量的TiO 2(10-100%wt%),得到MMT / CPX / TiO2多孔结构。 MMT / CPX / TiO 2(10%)纳米复合材料在模拟胃液中达到100%释放,而MMT / CPX和商业CPX分别在胃液中完成15小时和8小时的释放。在69小时内实现模拟血液中的最长CPX释放时间(30%),实现了MMT / CPX / TiO2(30%)。 CPX分子与结构之间的静电吸引是影响药物递送机制的主要原因。还支持Zeta电位测量,FTIR和XRD结果。 CPX释放配置文件适用于Korsmeyer-Peppas动力学模型,N值高于0.89,表示超级壳体II释放机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号